Published in Gut on April 01, 1997
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39
Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proc Natl Acad Sci U S A (1992) 3.61
Significance of systemic endotoxaemia in inflammatory bowel disease. Gut (1995) 2.21
Endotoxaemia in obstructive jaundice. HPB Surg (1991) 1.01
Endotoxin and the release of tumor necrosis factor receptors. Prog Clin Biol Res (1994) 1.00
Tumour necrosis factor soluble receptors behave as acute phase reactants following surgery in patients with rheumatoid arthritis, chronic osteomyelitis and osteoarthritis. Clin Exp Immunol (1993) 0.97
Influence of hospital and clinician workload on survival from colorectal cancer: cohort study. BMJ (1999) 2.98
Flexible sigmoidoscopy and the changing distribution of colorectal cancer: implications for screening. Gut (2001) 2.36
Guidelines for resection of colorectal cancer liver metastases. Gut (2006) 2.35
Changes in weight, fluid balance and serum albumin in patients referred for nutritional support. Clin Nutr (1999) 2.28
Significance of systemic endotoxaemia in inflammatory bowel disease. Gut (1995) 2.21
Humour experience in schizophrenia: relationship with executive dysfunction and psychosocial impairment. Psychol Med (2008) 1.99
The administration of an oral carbohydrate-containing fluid prior to major elective upper-gastrointestinal surgery preserves skeletal muscle mass postoperatively--a randomised clinical trial. Clin Nutr (2005) 1.88
Vacuum assisted closure system in the management of enterocutaneous fistulae. Postgrad Med J (2002) 1.85
Liver resection and transplantation in the management of iatrogenic biliary injury. World J Surg (2007) 1.83
Dilution and redistribution effects of rapid 2-litre infusions of 0.9% (w/v) saline and 5% (w/v) dextrose on haematological parameters and serum biochemistry in normal subjects: a double-blind crossover study. Clin Sci (Lond) (2001) 1.82
Bowel perforation caused by swallowed chicken bones--a case series. Ulster Med J (2007) 1.82
Blunt cardiac rupture. J Trauma (1984) 1.72
Association between early systemic inflammatory response, severity of multiorgan dysfunction and death in acute pancreatitis. Br J Surg (2006) 1.69
Problems with solutions: drowning in the brine of an inadequate knowledge base. Clin Nutr (2001) 1.67
Periampullary diverticula and pancreaticobiliary disease. Br J Surg (1999) 1.58
Development and reversibility of T lymphocyte dysfunction in experimental obstructive jaundice. Br J Surg (1990) 1.57
Open cholecystectomy in the laparoscopic era. Br J Surg (2007) 1.56
Bowel ischaemia and organ impairment in elective abdominal aortic aneurysm repair. Br J Surg (1994) 1.56
Renal dysfunction in obstructive jaundice. Br J Surg (1995) 1.53
Tumour necrosis factor and inflammatory bowel disease. Br J Surg (1997) 1.48
Risk assessment in acute pancreatitis. Br J Surg (2009) 1.47
Jass' classification revisited. J Am Coll Surg (1994) 1.45
What proportion of basic surgical trainees continue in a surgical career? A survey of the factors which are important in influencing career decisions. Surgeon (2009) 1.43
Randomized clinical trial of laxatives and oral nutritional supplements within an enhanced recovery after surgery protocol following liver resection. Br J Surg (2010) 1.39
Traumatic diaphragmatic rupture: associated injuries and outcome. Ann R Coll Surg Engl (2000) 1.39
A steroid stupor in a surgical ward. Br J Psychiatry (1991) 1.38
Sorry John--try again next year. Br Med J (1978) 1.38
Changing site distribution of colorectal cancer. BMJ (1992) 1.29
Prognostic factors in the palliation of pancreatic cancer. Eur J Surg Oncol (2003) 1.28
Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma. HPB (Oxford) (2007) 1.26
Prognostic factors in colorectal cancer. Br J Surg (1992) 1.25
Successful colonoscopy; completion rates and reasons for incompletion. Ulster Med J (2002) 1.24
Intestinal barrier dysfunction in clinical and experimental obstructive jaundice and its reversal by internal biliary drainage. Br J Surg (1996) 1.23
Incidence of benign pathology in patients undergoing hepatic resection for suspected malignancy. Surgeon (2003) 1.20
Postchemoembolisation syndrome--tumour necrosis or hepatocyte injury? Br J Cancer (2003) 1.19
Interleukin 10-deficient colitis: new similarities to human inflammatory bowel disease. Br J Surg (2000) 1.16
Incidental mucinous cystadenocarcinoma of the appendix. Postgrad Med J (1996) 1.13
Neuron-specific enolase as an aid to outcome prediction in head injury. Br J Neurosurg (1996) 1.13
Predictive value of soluble immunological mediators in neonatal infection. Clin Sci (Lond) (1994) 1.12
Reperfusion injury is greater with delayed restoration of venous outflow in concurrent arterial and venous limb injury. Br J Surg (2000) 1.12
Changes in nutritional status associated with obstructive jaundice and biliary drainage in rats. Am J Clin Nutr (1986) 1.11
Interstitial ablative techniques for hepatic tumours. Br J Surg (2003) 1.10
Selective decontamination of the digestive tract: a stratified, randomized, prospective study in a mixed intensive care unit. Surgery (1991) 1.10
Early specialist repair of biliary injury. Br J Surg (2006) 1.09
Peri-operative fluid and electrolyte management: a survey of consultant surgeons in the UK. Ann R Coll Surg Engl (2002) 1.07
Changes in gastrointestinal morphology associated with obstructive jaundice. J Pathol (2000) 1.07
Role of the gut in the pathophysiology of extrahepatic biliary obstruction. Gut (1996) 1.07
An audit of the management of patients with acute pancreatitis against national standards of practice. Br J Surg (2007) 1.05
Effects of extrahepatic obstructive jaundice on Kupffer cell clearance capacity. Arch Surg (1993) 1.05
Development and reversal of endotoxemia and endotoxin-related death in obstructive jaundice. Surgery (1990) 1.04
Pre-operative high sensitivity C-reactive protein and postoperative outcome in patients undergoing elective orthopaedic surgery. Anaesthesia (2007) 1.03
Hand grip strength--a simple prognostic indicator in surgical patients. JPEN J Parenter Enteral Nutr (1986) 1.03
The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg (1994) 1.03
Impaired specific cell-mediated immunity in experimental biliary obstruction and its reversibility by internal biliary drainage. J Surg Res (1986) 1.03
Variability in the adsorption properties of microtitre plates used as solid supports in enzyme immunoassay. Clin Chem (1980) 1.01
Cholangiocarcinoma arising after biliary-enteric drainage procedures for benign disease. Gut (2002) 1.01
Hepatic resection for benign non-cystic liver lesions. HPB (Oxford) (2004) 1.01
Probiotic therapy fails to improve gut permeability in a hapten model of colitis. Scand J Gastroenterol (2000) 1.01
Endotoxaemia in obstructive jaundice. HPB Surg (1991) 1.01
Profuse gastrointestinal haemorrhage due to delayed primary Epstein-Barr virus infection in an immunocompetent adult. Histopathology (2005) 1.00
Endotoxaemia and cytokine production in experimental colitis. Br J Surg (1995) 0.99
Early fasciotomy for acute clinically evident posttraumatic compartment syndrome. Am J Surg (1989) 0.98
Cytokine profile in chronic cardiac failure. Eur J Clin Invest (1996) 0.96
Colitis and colonic mucosal barrier dysfunction. Gut (1995) 0.96
Manipulation of the L-arginine-nitric oxide pathway in experimental colitis. Br J Surg (1995) 0.95
The extent of resection influences outcome following hepatectomy for colorectal liver metastases. Eur J Surg Oncol (2004) 0.95
Diagnosis and treatment of sphincter of Oddi dysfunction. Br J Surg (1998) 0.95
A population-based study of pancreatic trauma in Scotland. World J Surg (2006) 0.94
Incidental enterolithiasis. Ulster Med J (1989) 0.93
Conclusive evidence of endotoxaemia in biliary obstruction. Gut (1998) 0.93
Use of vacuum-assisted closure for healing of a persistent perineal sinus following panproctocolectomy: report of a case. Dis Colon Rectum (2004) 0.93
Mortality following lower limb ischemia-reperfusion: a systemic inflammatory response? World J Surg (1996) 0.93
The gastrointestinal tract as a barrier in sepsis. Br Med Bull (1999) 0.92
Kupffer cell blockade, tumour necrosis factor secretion and survival following endotoxin challenge in experimental biliary obstruction. Br J Surg (1999) 0.92
Mucins and CD56 as markers of tumour invasion and prognosis in periampullary cancer. Br J Surg (2010) 0.92
Palliation for suspected unresectable hilar cholangiocarcinoma. Eur J Surg Oncol (2006) 0.91
Adsorbents as antiendotoxin agents in experimental colitis. Gut (1993) 0.91
Hypotension-induced post-traumatic necrosis of the right colon. Am J Surg (1983) 0.91
Urgent thoracotomy for pulmonary or tracheobronchial injury. J Trauma (1988) 0.91
Patterns of bacterial translocation in experimental biliary obstruction. J Surg Res (2005) 0.90
Successful management of ileo-anal pouch volvulus. Colorectal Dis (2011) 0.89
Effect of supplemental L-arginine in a chemical-induced model of colorectal cancer. World J Surg (1996) 0.89
Lower limb ischaemia-reperfusion injury alters gastrointestinal structure and function. Br J Surg (1997) 0.89
Choledochal cysts in adults and their complications. HPB (Oxford) (2003) 0.89